Full-Time

Senior Manager

HCP Digital Marketing

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Develops insulin delivery systems for diabetes

Compensation Overview

$168.6k - $252.9k/yr

Senior, Expert

Acton, MA, USA

Hybrid

Requires on-site work from an Insulet office at least three (3) days per week.

Category
Growth Marketing
Growth & Marketing
Required Skills
Salesforce
Data Analysis
Requirements
  • A proven track record of leading successful digital HCP marketing campaigns in partnership with multiple stakeholders
  • Technical skills to deliver requirements to internal IT/marketing cloud teams
  • Experience partnering with internal website ARTs & Salesforce managers
  • Experience planning and executing across omni-digital channels (email, paid media, social, web, etc.)
  • Demonstrated strength in analytics to translate complex data into actionable insights
  • Comfortable in navigating between multiple projects and priorities in a dynamic, fast-paced environment, balancing strategic vision with hands-on execution
  • Ability to present to and influence all levels of the organization and senior leadership
  • Experience with demand-gen automation tools and CRM systems
  • Extensive knowledge of the HCP digital landscape, both traditional and emerging
  • Experience working with agencies and publishers to develop and produce engaging creative
  • Experience working at a fast-paced, high-growth company
  • Bachelor’s Degree
  • 8+ years of marketing experience
  • 5+ years of experience leading HCP digital marketing, including omnichannel campaigns
  • Experience working on digital media planning and/or execution within an agency or on the client-side
  • Experience at a medical device or pharmaceutical company, or an agency serving the industry
  • Travel approximately 25%
Responsibilities
  • Strike a balance between planning and activating multi-channel digital campaigns (email, paid media, social, web, etc.) in partnership with downstream marketing to attract and engage our HCPs
  • Lead the media agency on key digital strategies
  • Build the level of technical digital marketing skills with the team to drive development of multi-touch marketing campaigns
  • Lead and inspire stakeholders to embrace HCP digital marketing and adopt best-in-class engagement strategies
  • Collaborate with cross-functional teams to ensure seamless development and activation of highly impactful HCP media plans
  • Oversee and drive all owned channels for HCPs, including on Omnipod.com, social, and email lists
  • Champion a customer-centric approach, leveraging behavioral insights to refine targeting and messaging
  • Continuously experiment, analyze, and iterate to optimize digital performance
  • Stay abreast of industry trends and leverage innovative ways to improve the impact of digital activations
  • Establish a data-driven framework to define, track, and optimize key performance indicators (KPIs) across all digital HCP initiatives and campaigns
  • Implement A/B testing, audience segmentation, and personalization strategies to enhance engagement and conversion rates
  • Provide regular reports and insights to the leadership team on campaign performance, impact on business results, and further investment opportunities
Desired Qualifications
  • Experience with digital media planning and execution targeted towards healthcare providers
  • Experience managing blogs, KOL promotion, newsletters, and other narrative-based activation
  • Experience working at a fast-paced, high-growth company

Insulet Corporation develops and manufactures insulin delivery systems specifically for individuals with diabetes. Its main product, the Omnipod, is a tubeless and waterproof insulin pump that allows for continuous insulin infusion under the skin. This system offers a more convenient and discreet option compared to traditional insulin pumps that use tubing, making diabetes management easier for users. Insulet operates globally, with its headquarters in Acton, Massachusetts, and various manufacturing facilities around the world. The company focuses on selling the Omnipod system, which includes disposable pods and a personal diabetes manager (PDM). Insulet targets people with insulin-dependent diabetes who prefer a flexible and user-friendly method of insulin delivery. The company is also advancing its product line with innovations like the Omnipod 5, an automated insulin delivery system that works with continuous glucose monitors.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Omnipod 5 iPhone app launch enhances user experience with Dexcom G7 compatibility.
  • Insulet's humorous campaign and Marvel collaboration boost brand visibility and engagement.
  • $450M raised through senior notes optimizes capital structure for future growth.

What critics are saying

  • CEO transition may lead to strategic shifts or instability during the transition period.
  • Increased competition from Tandem Diabetes Care could impact Insulet's market share.
  • Integration of Omnipod 5 with Dexcom G7 may face technical challenges or user adoption issues.

What makes Insulet Corporation unique

  • Omnipod is tubeless and waterproof, unlike traditional insulin pumps with tubing.
  • Omnipod 5 integrates with CGMs, offering automated insulin delivery for personalized diabetes management.
  • Insulet's global presence and innovative product line set it apart in diabetes care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Diabetic Investor
Jun 25th, 2025
ADA 2025 - Winners and losers

It goes without saying that Insulet was not just the winner of ADA 2025 it won by a landslide.

TTF Valve
Jun 12th, 2025
Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility - Simply Wall St News

Insulet (NasdaqGS:PODD) launches Omnipod 5 iPhone App with Dexcom G7 compatibility - Simply Wall St news.

MediaPost
Jun 11th, 2025
Insulet Boosts Its Diabetes Device Via Comical Campaign - And A Comic Book

Insulet has launched a humorous paid social campaign for its wearable Omnipod 5 insulin delivery system - and teamed with Marvel for a stigma-busting comic book starring a teen heroine with diabetes.

RTTNews
Apr 28th, 2025
Insulet CEO Jim Hollingshead Resigns, Ashley McEvoy To Succeed; Raises Q1 Guidance

Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors.

MD+DI
Apr 28th, 2025
Insulet Names Ex-J&J MedTech Chief Ashley McEvoy as CEO

Ashley McEvoy has been tapped to be president and CEO of Insulet.